Cellis was present at the Inaugural AACR Immuno-Oncology (IO) Conference, held in Los Angeles from February 23-26, 2025. This landmark event, organized by the American Association for Cancer Research (AACR), brought together global leaders in immunology, inflammation, and immunotherapy research to discuss the latest advancements in cancer treatment.
As a company focused on innovative macrophage-based cell therapies, Cellis is committed to contributing to the evolving landscape of immuno-oncology. Events like AACR IO are crucial for fostering collaboration, sharing cutting-edge research, and shaping the future of cancer treatment.
We extend our thanks to the AACR and the conference organizers for creating this outstanding platform for collaboration and scientific exchange.
